Albany - New York, Sept. 27, 2016 -- A new Transparency Market Research report states that the global synthetic biology market stood at US$1.8 bn in 2012 and is predicted to reach US$13.4 bn by 2019. It is predicted to expand at a whopping CAGR of 32.60% from 2013 to 2019. The title of the report is “Synthetic Biology Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019.”
Synthetic biology refers to an interdisciplinary branch of engineering and biology. It aims at the fabrication and redesign of biological systems and components that do not already exist in the natural world. Synthetic biology combines the increasing knowledge of genomics with the chemical synthesis of DNA for enabling researchers to quickly manufacture catalogued DNA sequences.
Browse Research Report on Synthetic Biology Market:
http://www.transparencymarketresearch.com/synthetic-biology-market.html
The increasing demand for enhanced vaccines and drugs and the development of molecular biology are amongst the chief factors fuelling the synthetic biology market. In addition, the participation and encouragement of universities and government bodies in synthetic biology research and the rising demand for genetically modified crops owing to the increasing global population are also amongst the chief factors fuelling the market for synthetic biology. On the other hand, the increasing regulations and the soaring costs of synthetic biology techniques may impede the growth of the market in the coming years.
On the basis of product, the report segments the market for synthetic biology into core products and enabling products. Amongst these, core products are further segmented into synthetic genes, synthetic DNA, synthetic cells, chassis organisms, and XNA (xeno nucleic acid). On the other hand, enabling products are further segmented into oligonucleotide synthesis and DNA synthesis. Amongst these, the segment of synthetic DNA led the market in 2012 due to the increasing commercial availability of synthetic DNA. On the basis of technology, the market is segmented into DNA sequencing, genome engineering, biological components and integrated systems, and bioinformatics. Amongst these, genome engineering technology can be utilized for modifying genetic foods, gene therapy, and gene cloning.
On the basis of application, the synthetic biology market is segmented into chemicals, healthcare, agriculture, and others including R&D, biosecurity, and energy and environment. Amongst these, synthetic biology has the largest application in the healthcare sector owing to the increasing use of synthetic biology for producing cheap vaccines and drugs. On the other hand, the segment of agriculture is poised to expand at the highest CAGR from 2013 to 2019.
Download Sample Report Copy or for further inquiries, click here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421
In terms of geography, the report segments the market into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, in 2012, Europe led the market for synthetic biology and is predicted to expand consistently due to the rising initiatives of private organizations and governments for the development of synthetic biology in this region. On the other hand, North America held the second largest share in the market in the same year due to the rising proliferation of novel technologies in this region. The region of Asia Pacific is also poised to experience rapid growth in the market owing to increasing support from international organizations for the development of synthetic biology.
As per the report, the key players operating in the market are Agrivida, Inc., Biosearch Technologies, Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporationand others
Browse Press Release on Synthetic Biology Market: http://www.transparencymarketresearch.com/pressrelease/synthetic-biology-market.htm
The global synthetic biology market is segmented into the following categories:
Synthetic Biology Market, by Products
- Core Products
- Synthetic DNA
- Synthetic Genes
- Synthetic Cells
- XNA (Xeno Nucleic Acid)
- Chassis Organisms
- Enabling Products
- DNA Synthesis
- Oligonucleotide Synthesis
Synthetic Biology Market, by Technologies
- Genome Engineering
- DNA Sequencing
- Bioinformatics
- Biological Components and Integrated Systems
Synthetic Biology Market, by Applications
- Healthcare
- Chemicals (Including Bio-Fuels)
- Agriculture
- Others (Biosecurity, R&D, Energy and Environment)
Synthetic Biology Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Browse Other Latest Research Reports:
- Global Bioinformatics Market: http://www.transparencymarketresearch.com/bioinformatics-market.html
- Genome Engineering Market: http://www.transparencymarketresearch.com/genome-editing-engineering-market.html
- DNA Sequencing In Drug Discovery Market: http://www.transparencymarketresearch.com/dna-sequencing-drug-discovery-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact Rohit Bhisey 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Robinhood Expands Sports Event Contracts With Player Performance Wagers
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Shell M&A Chief Exits After BP Takeover Proposal Rejected
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



